MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response

V GONzáLEz-QuINTANA… - Oncology …, 2016 - spandidos-publications.com
… Studies of >40 miRNAs with roles in cancer regulation were identified. We also identified 17
miRNAs associated with progression, 12 involved with clinical outcome and 7 that improved …

Cervical cancer

SE Waggoner - The lancet, 2003 - thelancet.com
… The primary cause in development of cervical cancer is … Other factors associated with
development of cervical cancer … also at increased risk of development of cervical cancer. Cigarette …

Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer

B Czerniak, D Olszewska-Słonina - … Oncology/Współczesna Onkologia, 2018 - termedia.pl
… is significantly lowered and correlated with tumour development, poor prognosis in human
cervical cancer, and higher incidence of lymph node metastasis, which is indicative of its …

Cervical cancer: are there potential new targets? An update on preclinical and clinical results

F Tomao, C Di Tucci, L Imperiale… - Current drug …, 2014 - ingentaconnect.com
… cells or present in its microenvironment and involved in tumor growth, progression or survival.
We will discuss potential molecular targets and new targeted therapies that have been …

[HTML][HTML] Treatment and clinical outcomes of cervical cancer during pregnancy

J Ma, L Yu, F Xu, H Yi, W Wei, P Wu, S Wu… - Annals of …, 2019 - ncbi.nlm.nih.gov
… Second, pregnancy may be harmful to the progression of cervical cancer. Finally, our
report showed little benefit associated with chemotherapy in the treatment of this disease. …

Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types

HC Lai, CA Sun, MH Yu, HJ Chen… - … journal of cancer, 1999 - Wiley Online Library
… glandular differentiation on cancer development; third, HPV may infect reserve cells having
multiple potentials to develop into squamous-cell, adeno- or adenosquamous carcinomas. …

[HTML][HTML] Management and clinical outcomes of pregnant patients with invasive cervical cancer

N Germann, C Haie-Meder, P Morice, C Lhomme… - Annals of oncology, 2005 - Elsevier
clinical outcomes and to discuss the management of women presenting with an invasive
cervical cancer … One patient developed a vaginal recurrence at 18 months after diagnosis, but …

Incidence, treatment and outcomes of cervical cancer in low-and middle-income countries

U Mahantshetty, G Lavanya, S Grover, CA Akinfenwa… - Clinical Oncology, 2021 - Elsevier
clinicians' review, we highlight the incidence, treatment and clinical outcomes of cervical
cancer in low-… The outcomes of women with cervical cancer in developing countries are lower …

The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis

J Ma, L Ke, Q Liu - Medicine, 2018 - journals.lww.com
cervical cancer die due to disease recurrence or progression. For patients with early stage
cervical cancer… Presently, many tumor-specific parameters are identified as prognostic factors …

Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer

ML Zhu, M Feng, F He, BC Han, K Ma, XY Zeng… - Clinica chimica acta, 2018 - Elsevier
… Nowadays, the prediction of cervical cancer progression or recurrence is mainly using the
postoperative prognostic factors, such as lymph node (LN) status, histologic grade and depth …